Precog, Llc.
Clinical trials sponsored by Precog, Llc., explained in plain language.
-
New drug combo aims to keep lung cancer at bay longer
Disease control Not yet recruitingThis study tests whether adding tarlatamab to durvalumab after standard chemotherapy and radiation can delay cancer return and extend life in people with limited-stage small cell lung cancer. Tarlatamab works by helping immune cells recognize and attack cancer cells. About 430 pa…
Phase: PHASE3 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New hope for myeloma patients: could a smart drug outperform standard therapy?
Disease control Not yet recruitingThis phase 3 trial will compare two drug combinations for people newly diagnosed with multiple myeloma who are not eligible for or refuse a stem cell transplant. About 500 participants will receive either belantamab mafodotin or daratumumab, both combined with standard drugs (bor…
Phase: PHASE3 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC